Cargando…
Brève : Covid -19 : léflunomide proposé pour les patients cancéreux
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604219/ https://www.ncbi.nlm.nih.gov/pubmed/33163090 http://dx.doi.org/10.1016/S1773-035X(20)30281-1 |
| _version_ | 1783604096973930496 |
|---|---|
| author | Manus, Jean-Marie |
| author_facet | Manus, Jean-Marie |
| author_sort | Manus, Jean-Marie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7604219 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76042192020-11-02 Brève : Covid -19 : léflunomide proposé pour les patients cancéreux Manus, Jean-Marie Rev Francoph Lab Article Elsevier Masson SAS. 2020-11 2020-10-31 /pmc/articles/PMC7604219/ /pubmed/33163090 http://dx.doi.org/10.1016/S1773-035X(20)30281-1 Text en Copyright © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Manus, Jean-Marie Brève : Covid -19 : léflunomide proposé pour les patients cancéreux |
| title | Brève : Covid -19 : léflunomide proposé pour les patients cancéreux |
| title_full | Brève : Covid -19 : léflunomide proposé pour les patients cancéreux |
| title_fullStr | Brève : Covid -19 : léflunomide proposé pour les patients cancéreux |
| title_full_unstemmed | Brève : Covid -19 : léflunomide proposé pour les patients cancéreux |
| title_short | Brève : Covid -19 : léflunomide proposé pour les patients cancéreux |
| title_sort | brève : covid -19 : léflunomide proposé pour les patients cancéreux |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604219/ https://www.ncbi.nlm.nih.gov/pubmed/33163090 http://dx.doi.org/10.1016/S1773-035X(20)30281-1 |
| work_keys_str_mv | AT manusjeanmarie brevecovid19leflunomideproposepourlespatientscancereux |